OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Are there distinct clinical and pathological features distinguishing idiopathic from drug-induced subacute cutaneous lupus erythematosus? A European retrospective multicenter study
Federica Guicciardi, Laura Atzori, Angelo Valerio Marzano, et al.
Journal of the American Academy of Dermatology (2019) Vol. 81, Iss. 2, pp. 403-411
Closed Access | Times Cited: 35
Federica Guicciardi, Laura Atzori, Angelo Valerio Marzano, et al.
Journal of the American Academy of Dermatology (2019) Vol. 81, Iss. 2, pp. 403-411
Closed Access | Times Cited: 35
Showing 1-25 of 35 citing articles:
Pembrolizumab- induced subacute cutaneous lupus erythematosus in a patient with oropharyngeal squamous cell carcinoma: A case report and literature review
Beate Mayer, Pavel Babál, Lucia Krivošíková
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access | Times Cited: 1
Beate Mayer, Pavel Babál, Lucia Krivošíková
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access | Times Cited: 1
Cutaneous Manifestations of “Lupus”: Systemic Lupus Erythematosus and Beyond
Elizabeth Cooper, Catherine Pisano, Samantha C. Shapiro
International Journal of Rheumatology (2021) Vol. 2021, pp. 1-19
Open Access | Times Cited: 45
Elizabeth Cooper, Catherine Pisano, Samantha C. Shapiro
International Journal of Rheumatology (2021) Vol. 2021, pp. 1-19
Open Access | Times Cited: 45
Current Concepts and Future Approaches in the Treatment of Cutaneous Lupus Erythematosus: A Comprehensive Review
François Chasset, Camille Françès
Drugs (2019) Vol. 79, Iss. 11, pp. 1199-1215
Open Access | Times Cited: 31
François Chasset, Camille Françès
Drugs (2019) Vol. 79, Iss. 11, pp. 1199-1215
Open Access | Times Cited: 31
Cutaneous lupus erythematosus induced by drugs - novel insights
Robert Borucki, Victoria P. Werth
Expert Review of Clinical Pharmacology (2019) Vol. 13, Iss. 1, pp. 35-42
Closed Access | Times Cited: 30
Robert Borucki, Victoria P. Werth
Expert Review of Clinical Pharmacology (2019) Vol. 13, Iss. 1, pp. 35-42
Closed Access | Times Cited: 30
British Association of Dermatologists guidelines for the management of people with cutaneous lupus erythematosus 2021
Donal O’Kane, Collette McCourt, Simon Meggitt, et al.
British Journal of Dermatology (2021) Vol. 185, Iss. 6, pp. 1112-1123
Closed Access | Times Cited: 23
Donal O’Kane, Collette McCourt, Simon Meggitt, et al.
British Journal of Dermatology (2021) Vol. 185, Iss. 6, pp. 1112-1123
Closed Access | Times Cited: 23
Cutaneous drug-induced lupus erythematosus: Clinical and immunological characteristics and update on new associated drugs
Pauline Bataille, François Chasset, J.‐B. Monfort, et al.
Annales de Dermatologie et de Vénéréologie (2021) Vol. 148, Iss. 4, pp. 211-220
Open Access | Times Cited: 18
Pauline Bataille, François Chasset, J.‐B. Monfort, et al.
Annales de Dermatologie et de Vénéréologie (2021) Vol. 148, Iss. 4, pp. 211-220
Open Access | Times Cited: 18
Widespread subacute cutaneous lupus erythematosus in a patient receiving checkpoint inhibitor immunotherapy with ipilimumab and nivolumab
Cory Kosche, Joshua L. Owen, Jennifer Choi
Dermatology Online Journal (2019) Vol. 25, Iss. 10
Open Access | Times Cited: 21
Cory Kosche, Joshua L. Owen, Jennifer Choi
Dermatology Online Journal (2019) Vol. 25, Iss. 10
Open Access | Times Cited: 21
De novo subacute cutaneous lupus erythematosus‐like eruptions in the setting of programmed death‐1 or programmed death ligand‐1 inhibitor therapy: clinicopathological correlation
Ai‐Tram N. Bui, Jesse Hirner, Sean Singer, et al.
Clinical and Experimental Dermatology (2020) Vol. 46, Iss. 2, pp. 328-337
Closed Access | Times Cited: 20
Ai‐Tram N. Bui, Jesse Hirner, Sean Singer, et al.
Clinical and Experimental Dermatology (2020) Vol. 46, Iss. 2, pp. 328-337
Closed Access | Times Cited: 20
The pathogenesis of cutaneous lupus erythematosus: The aberrant distribution and function of different cell types in skin lesions
Xinyu Zhou, Jin-Li Yan, Qianjin Lu, et al.
Scandinavian Journal of Immunology (2020) Vol. 93, Iss. 1
Open Access | Times Cited: 16
Xinyu Zhou, Jin-Li Yan, Qianjin Lu, et al.
Scandinavian Journal of Immunology (2020) Vol. 93, Iss. 1
Open Access | Times Cited: 16
Cutaneous manifestations of lupus erythematosus: a practical clinicopathological review for pathologists
Carole Bitar, Tyler D. Menge, May P. Chan
Histopathology (2021) Vol. 80, Iss. 1, pp. 233-250
Open Access | Times Cited: 15
Carole Bitar, Tyler D. Menge, May P. Chan
Histopathology (2021) Vol. 80, Iss. 1, pp. 233-250
Open Access | Times Cited: 15
Cutaneous drug eruptions including serum sickness-like reaction, symmetrical drug-related intertriginous and flexural exanthema, and drug-induced lupus
K. McNamara, Olivia Hughes, Lindsay C. Strowd
Clinics in Dermatology (2020) Vol. 38, Iss. 6, pp. 641-647
Closed Access | Times Cited: 8
K. McNamara, Olivia Hughes, Lindsay C. Strowd
Clinics in Dermatology (2020) Vol. 38, Iss. 6, pp. 641-647
Closed Access | Times Cited: 8
Drug-induced lupus erythematosus
Ana L. Gouveia, Margarida Gonçalo
Portuguese Journal of Dermatology and Venereology (2023) Vol. 81, Iss. 3
Open Access | Times Cited: 3
Ana L. Gouveia, Margarida Gonçalo
Portuguese Journal of Dermatology and Venereology (2023) Vol. 81, Iss. 3
Open Access | Times Cited: 3
Anti‐tumour necrosis factor‐induced skin rashes in inflammatory bowel disease: a systematic review and evidence‐based management algorithm
Minnie Au, Georgina Heddle, Edward J. Young, et al.
Internal Medicine Journal (2022) Vol. 53, Iss. 10, pp. 1854-1865
Closed Access | Times Cited: 5
Minnie Au, Georgina Heddle, Edward J. Young, et al.
Internal Medicine Journal (2022) Vol. 53, Iss. 10, pp. 1854-1865
Closed Access | Times Cited: 5
Characterization of drug-induced cutaneous lupus: Analysis of 1994 cases using the WHO pharmacovigilance database
Lou Kawka, Philippe Mertz, François Chasset, et al.
Autoimmunity Reviews (2020) Vol. 20, Iss. 1, pp. 102705-102705
Closed Access | Times Cited: 7
Lou Kawka, Philippe Mertz, François Chasset, et al.
Autoimmunity Reviews (2020) Vol. 20, Iss. 1, pp. 102705-102705
Closed Access | Times Cited: 7
Analysis of clinical characteristics of drug-induced cutaneous lupus erythematosus in men
Amy J. Petty, Adela R. Cardones, Anne L. Marano
Journal of the American Academy of Dermatology (2020) Vol. 83, Iss. 5, pp. 1455-1457
Open Access | Times Cited: 6
Amy J. Petty, Adela R. Cardones, Anne L. Marano
Journal of the American Academy of Dermatology (2020) Vol. 83, Iss. 5, pp. 1455-1457
Open Access | Times Cited: 6
Omeprazole-Induced Subacute Cutaneous Lupus Erythematosus
Elizabeth Hall, Rahul Peravali, Tejesh Patel
JAMA Dermatology (2020) Vol. 156, Iss. 9, pp. 1013-1013
Open Access | Times Cited: 5
Elizabeth Hall, Rahul Peravali, Tejesh Patel
JAMA Dermatology (2020) Vol. 156, Iss. 9, pp. 1013-1013
Open Access | Times Cited: 5
A case of paraneoplastic subacute cutaneous lupus erythematosus in a patient with metastatic melanoma
Jonathan D. D’Gama, David A. Hashemi, Flavia Fedeles
JAAD Case Reports (2021) Vol. 15, pp. 88-91
Open Access | Times Cited: 5
Jonathan D. D’Gama, David A. Hashemi, Flavia Fedeles
JAAD Case Reports (2021) Vol. 15, pp. 88-91
Open Access | Times Cited: 5
Amlodipine-Induced Subacute Cutaneous Lupus Erythematosus Localized to Non-Sun-Exposed Areas
Takahiro Mizuta, Miyuki Kato
Case Reports in Dermatology (2022) Vol. 14, Iss. 1, pp. 71-76
Open Access | Times Cited: 3
Takahiro Mizuta, Miyuki Kato
Case Reports in Dermatology (2022) Vol. 14, Iss. 1, pp. 71-76
Open Access | Times Cited: 3
Lupus Erythematosus and Antiphospholipid Syndrome
Jan Dutz, Touraj Khosravi‐Hafshejani
(2024), pp. 1-62
Closed Access
Jan Dutz, Touraj Khosravi‐Hafshejani
(2024), pp. 1-62
Closed Access
Bevacizumab-Induced Cutaneous Lupus Erythematosus in a Patient With Metastatic Colon Carcinoma: A Case Report
Sethi Ashish, Moses S. Raj, Eric Zhuang
Cureus (2024)
Open Access
Sethi Ashish, Moses S. Raj, Eric Zhuang
Cureus (2024)
Open Access
Subacute Cutaneous Lupus Erythematosus Secondary to Intravenous Immunoglobulin Infusions
Taylor Fleshman, Ian Depew, William T Snider, et al.
Cureus (2024)
Open Access
Taylor Fleshman, Ian Depew, William T Snider, et al.
Cureus (2024)
Open Access
Paraneoplastic subacute cutaneous lupus erythematosus in a patient with metastatic melanoma
Georgina Heddle, Alain Tran, Erwin Foster‐Smith, et al.
Australasian Journal of Dermatology (2023) Vol. 64, Iss. 1, pp. 138-140
Closed Access | Times Cited: 1
Georgina Heddle, Alain Tran, Erwin Foster‐Smith, et al.
Australasian Journal of Dermatology (2023) Vol. 64, Iss. 1, pp. 138-140
Closed Access | Times Cited: 1
Immunohistochemical Study of the PD-1/PD-L1 Pathway in Cutaneous Lupus Erythematosus
Zsófia Király, Ágota Szepesi, Anna Sebestyén, et al.
Pathology & Oncology Research (2022) Vol. 28
Open Access | Times Cited: 2
Zsófia Király, Ágota Szepesi, Anna Sebestyén, et al.
Pathology & Oncology Research (2022) Vol. 28
Open Access | Times Cited: 2
Erythema multiforme‐like drug eruption in a patient with systemic lupus erythematosus treated with leflunomide
Yuqing Hu, Zhanglei Mu, Jianzhong Zhang
Dermatologic Therapy (2020) Vol. 33, Iss. 3
Open Access | Times Cited: 1
Yuqing Hu, Zhanglei Mu, Jianzhong Zhang
Dermatologic Therapy (2020) Vol. 33, Iss. 3
Open Access | Times Cited: 1
A case of recombinant human follitropin alfa-induced subacute cutaneous lupus erythematosus presenting with erythema multiforme-like lesion
Lanqi Wang, Selena Chen, Qiang Ju
Lupus (2020) Vol. 29, Iss. 13, pp. 1824-1825
Closed Access | Times Cited: 1
Lanqi Wang, Selena Chen, Qiang Ju
Lupus (2020) Vol. 29, Iss. 13, pp. 1824-1825
Closed Access | Times Cited: 1
